Skip to main navigation menu Skip to main content Skip to site footer

Original article

Vol. 141 No. 0910 (2011)

Swiss Interdisciplinary Management Programme for Heart Failure (SWIM-HF)

  • K Denhaerynck
  • A Conca-Zeller
  • AT Bernasconi
  • Froelicher Sivarajan
  • Geest De
Cite this as:
Swiss Med Wkly. 2011;141:w13171


PRINCIPLES: International guidelines for heart failure (HF) care recommend the implementation of inter-professional disease management programmes. To date, no such programme has been tested in Switzerland. The aim of this randomised controlled trial (RCT) was to test the effect on hospitalisation, mortality and quality of life of an adult ambulatory disease management programme for patients with HF in Switzerland.

METHODS:Consecutive patients admitted to internal medicine in a Swiss university hospital were screened for decompensated HF. A total of 42 eligible patients were randomised to an intervention (n = 22) or usual care group (n = 20). Medical treatment was optimised and lifestyle recommendations were given to all patients. Intervention patients additionally received a home visit by a HF-nurse, followed by 17 telephone calls of decreasing frequency over 12 months, focusing on self-care. Calls from the HF nurse to primary care physicians communicated health concerns and identified goals of care. Data were collected at baseline, 3, 6, 9 and 12 months. Mixed regression analysis (quality of life) was used. Outcome assessment was conducted by researchers blinded to group assignment.

RESULTS:After 12 months, 22 (52%) patients had an all-cause re-admission or died. Only 3 patients were hospitalised with HF decompensation. No significant effect of the intervention was found on HF related to quality of life.

CONCLUSIONS:An inter-professional disease management programme is possible in the Swiss healthcare setting but effects on outcomes need to be confirmed in larger studies.


  1. Cardiovascular diseases: Fact sheet N°317. 2010 [cited March 7, 2010] Available from:
  2. Lloyd-Jones D, Adams RJ, Brown TM, Carnethon M, Dai S, De Simone G, et al. Heart disease and stroke statistics – 2010 update: a report from the American Heart Association. Circulation. 2010;121:e46–e215.
  3. Dickstein K, Cohen-Solal A, Filippatos G, McMurray JJ, Ponikowski P, Poole-Wilson PA, et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur J Heart Fail. 2008;10:933–89.
  4. Jhund PS, Macintyre K, Simpson CR, Lewsey JD, Stewart S, Redpath A, et al. Long-term trends in first hospitalization for heart failure and subsequent survival between 1986 and 2003: a population study of 5.1 million people. Circulation. 2009;119:515–23.
  5. Ritter M, Laule-Kilian K, Klima T, Christ A, Christ M, Perruchoud A, et al. Gender differences in acute congestive heart failure. Swiss Med Wkly. 2006;136:311–7.
  6. Stewart S, Jenkins A, Buchan S, McGuire A, Capewell S, McMurray JJ. The current cost of heart failure to the National Health Service in the UK. Eur J Heart Fail. 2002;4:361–71.
  7. Ross JS, Chen J, Lin Z, Bueno H, Curtis JP, Keenan PS, et al. Recent national trends in readmission rates after heart failure hospitalization. Circ Heart Fail. 2010;3:97–103.
  8. Dunlay SM, Gheorghiade M, Reid KJ, Allen LA, Chan PS, Hauptman PJ, et al. Critical elements of clinical follow-up after hospital discharge for heart failure: insights from the EVEREST trial. Eur J Heart Fail. 2010;12:367–74.
  9. Whellan DJ, Hasselblad V, Peterson E, O'Connor CM, Schulman KA. Metaanalysis and review of heart failure disease management randomized controlled clinical trials. Am Heart J. 2005;149:722–9.
  10. McAlister FA, Stewart S, Ferrua S, McMurray JJ. Multidisciplinary strategies for the management of heart failure patients at high risk for admission: a systematic review of randomized trials. J Am Coll Cardiol. 2004;44:810–9.
  11. Phillips CO, Singa RM, Rubin HR, Jaarsma T. Complexity of program and clinical outcomes of heart failure disease management incorporating specialist nurse-led heart failure clinics. A meta-regression analysis. Eur J Heart Fail. 2005;7:333–41.
  12. Phillips CO, Wright SM, Kern DE, Singa RM, Shepperd S, Rubin HR. Comprehensive discharge planning with postdischarge support for older patients with congestive heart failure: a meta-analysis. Jama: the Journal of the American Medical Association 2004;291:1358–67.
  13. Brunner-La Rocca HP, F. W, Trigo-Trindade P, Leventhal M, Seydoux C, Schmid JP, et al. Empfehlungen zur Diagnose und Behandlung der Herzinsuffizienz Teil 1: ambulante Betreuung. Schweiz Med Forum. 2007;7:3S–14S.
  14. Buser P, H.P. B-LR, Leventhal M, Mahrer R, Mohacsi P, Nuesch K, et al. Empfehlungen zur vernetzten Betreuung von Herzinsuffizienzpatienten in der Schweiz. Schweiz Ärztezeitung. 2006;87:1943–52.
  15. Peytremann-Bridevaux I, Burnand B. Inventory and perspectives of chronic disease management programs in Switzerland: an exploratory survey. Int J Integr Care. 2009;9:e93.
  16. Jessup M, Abraham WT, Casey DE, Feldman AM, Francis GS, Ganiats TG, et al. 2009 focused update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation. Circulation. 2009;119:1977–2016.
  17. Heart Failure Society of America. HFSA 2006 Comprehensive Heart Failure Practice Guideline. J Card Fail. 2006;12:e1–2.
  18. Folstein M, Folstein S, McHugh P. Mini-mental state: A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189–98.
  19. Charlson M, Szatrowski TP, Peterson J, Gold J. Validation of a combined comorbidity index. J Clin Epidemiol. 1994;47:1245–51.
  20. Goldman L, Hashimoto B, Cook EF, Loscalzo A. Comparative reproducibility and validity of systems for assessing cardiovascular functional class: advantages of a new specific activity scale. Circulation. 1981;64:1227–34.
  21. Cleemput I, Kesteloot K, Moons P, Vanrenterghem Y, Van Hooff JP, Squifflet JP, et al. The construct and concurrent validity of the EQ-5D in a renal transplant population. Value Health. 2004;7:499–509.
  22. Rector TS, Kubo SH, Cohn JN. Patients’ Self-Assessment of Their Congestive Heart Failure. Part 2: Content, Reliability and Validity of a New Measure, The Minnesota Living with Heart Failure Questionnaire. Heart Failure 1987; October/November: 198–200, 205–209.
  23. Bandura A. Self-efficacy: The exercise of control. New York: W.H. Freeman; 1997.
  24. Krumholz HM, Currie PM, Riegel B, Phillips CO, Peterson ED, Smith R, et al. A taxonomy for disease management: a scientific statement from the American Heart Association Disease Management Taxonomy Writing Group. Circulation. 2006;114:1432–45.
  25. Brunner-La Rocca HP, Buser PT, Schindler R, Bernheim A, Rickenbacher P, Pfisterer M. Management of elderly patients with congestive heart failure – design of the Trial of Intensified versus standard Medical therapy in Elderly patients with Congestive Heart Failure (TIME-CHF). Am Heart J. 2006;151:949–55.
  26. Krumholz HM, Amatruda J, Smith GL, Mattera JA, Roumanis SA, Radford MJ, et al. Randomized trial of an education and support intervention to prevent readmission of patients with heart failure. J Am Coll Cardiol. 2002;39:83–9.
  27. Jaarsma T, van der Wal MH, Lesman-Leegte I, Luttik ML, Hogenhuis J, Veeger NJ, et al. Effect of moderate or intensive disease management program on outcome in patients with heart failure: Coordinating Study Evaluating Outcomes of Advising and Counseling in Heart Failure (COACH). Arch Intern Med. 2008;168:316–24.
  28. De Geest S, Moons P, Callens B, Gut C, Lindpaintner L, Spirig R. Introducing Advanced Practice Nurses / Nurse Practitioners in health care systems: a framework for reflection and analysis. Swiss Med Wkly. 2008;138:621–8.
  29. Pfisterer M, Buser P, Rickli H, Gutmann M, Erne P, Rickenbacher P, et al. BNP-guided vs symptom-guided heart failure therapy: the Trial of Intensified vs Standard Medical Therapy in Elderly Patients With Congestive Heart Failure (TIME-CHF) randomized trial. JAMA. 2009;301:383–92.
  30. Meyer K, Murner N, Laederach-Hofmann K, Simmet A, Hess OM. Heart failure events, and case fatalities in Switzerland based on hospital statistics and cause of death statistics. Swiss Med Wkly. 2008;138:506–11.
  31. Randomised trial of telephone intervention in chronic heart failure: DIAL trial. BMJ. 2005;331:425.
  32. Ferrante D, Varini S, Macchia A, Soifer S, Badra R, Nul D, et al. Long-term results after a telephone intervention in chronic heart failure: DIAL (Randomized Trial of Phone Intervention in Chronic Heart Failure) follow-up. J Am Coll Cardiol. 2010;56:372–8.